Mink Therapeutics Inc
NASDAQ:INKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
Cross-Harbour Holdings Ltd
HKEX:32
|
HK |
|
BioNTech SE
NASDAQ:BNTX
|
DE |
|
Audax Renovables SA
MAD:ADX
|
ES |
|
Phunware Inc
NASDAQ:PHUN
|
US |
|
N
|
NOS SGPS SA
ELI:NOS
|
PT |
|
I
|
Iss A/S
XMUN:QJQ
|
DK |
|
N
|
Nedbank Group Ltd
JSE:NED
|
ZA |
|
A
|
ASN Broker PCL
SET:ASN
|
TH |
|
C
|
CAE Inc
NYSE:CAE
|
CA |
|
C
|
Compal Electronics Inc
TWSE:2324
|
TW |
|
P
|
Philip Morris International Inc
SIX:PMI
|
US |
|
Amphenol Corp
NYSE:APH
|
US |
|
D
|
Diageo PLC
OTC:DGEAF
|
UK |
|
S
|
Serta Simmons Bedding LLC
NASDAQ:SRTA
|
US |
|
Synopsys Inc
MIL:1SNPS
|
US |
|
Reliance Steel & Aluminum Co
NYSE:RS
|
US |
|
S
|
Stainless Tankers ASA
F:ZC0
|
NO |
|
Pebble Group PLC
LSE:PEBB
|
UK |
|
A
|
Arctic Paper SA
WSE:ATC
|
PL |
|
D
|
Dimand Societe Anonyme for The Use and Construction of Real Estate Constructions Services and Participations
ATHEX:DIMAND
|
GR |
|
N
|
NVIDIA Corp
DUS:NVD
|
US |
|
Danaos Corp
NYSE:DAC
|
GR |
|
S
|
Swire Pacific Ltd
F:SWI
|
HK |
Wall St Price Targets
INKT Price Targets Summary
Mink Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
INKT is 39.78 USD with a low forecast of 35.35 USD and a high forecast of 45.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INKT's stock price target?
Price Target
39.78
USD
According to Wall Street analysts, the average 1-year price target for
INKT is 39.78 USD with a low forecast of 35.35 USD and a high forecast of 45.15 USD.